To evaluate the efficacy and safety of single combined (long- or short-acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
This is a protocol.
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
You may also be interested in:
- Does adding tiotropium, a long-acting muscarinic antagonist (LAMA), to combination therapy (LABA/ICS) help to control asthma?
- Does adding a long-acting muscarinic antagonist (LAMA) to an inhaled steroid help people with uncontrolled asthma more than an inhaled steroid alone?
- For people with uncontrolled asthma on inhaled steroids, is it better to increase the dose or add a long-acting muscarinic antagonist?
- Is it better to add long-acting muscarinic antagonists or long-acting beta2-agonists to inhaled corticosteroids for people with uncontrolled asthma?
- What is the evidence for stopping long-acting beta2-agonists for adults with stable asthma using combination therapy?